Upstream Bio, Inc.
UPB
$8.56
-$0.09-1.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.38% | -32.83% | -25.07% | -17.37% | 7.94% |
| Total Depreciation and Amortization | -12.24% | 250.00% | 7.69% | 0.00% | -7.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.33% | 123.17% | 202.85% | 55.18% | -971.48% |
| Change in Net Operating Assets | -1,035.96% | -283.82% | -42.04% | 132.02% | 4.10% |
| Cash from Operations | -109.90% | -40.47% | -9.09% | 27.12% | -9.01% |
| Capital Expenditure | -- | 43.25% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -606.93% | 2,326.11% | 103.38% | -471.07% | 364.25% |
| Cash from Investing | -609.17% | 2,874.31% | 102.74% | -471.07% | 364.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1,435,431.58% | -66.07% | -99.40% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.44% | -31.20% | -2,396.24% | -- | -- |
| Cash from Financing | -100.01% | 16,592.87% | -102.19% | 698.46% | 7,157.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.90% | 2,163.86% | -232.02% | 89.39% | 126.42% |